Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prostatic Neoplasms, Castration-Resistant × Radium-223 × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6 Prostatic Neoplasms, Castration-Resistant 1 Pain 1 Neoplasm Metastasis 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Fatigue 1 Carcinoma, Renal Cell 1

Interventions

enzalutamide 6 radium Ra 223 dichloride 4 Abiraterone Acetate 2 zimberelimab 1 xentuzumab 1 sacituzumab govitecan 1 quemliclustat 1 pembrolizumab 1 atezolizumab 1 apalutamide 1 Standard of Care 1 Radium-223 1 Nivolumab 1 Ipilimumab 1 Drug Therapy 1 Docetaxel 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03563014 2020-05-20

BELFIGO

Bayer

Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡